Arkolith/Insider Trading/QNRX/Form 4

Myers Michael

Chief Executive Officer, DirectorQuoin Pharmaceuticals, Ltd. (QNRX) · full profile →Form 4 · filed Dec 27, 2024
Net Buying
Open-Market Buys
$250K
Open-Market Sells
$0
Net Open-Market Flow
$250K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2024Buy(P)556K$0.45$250K603K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2024Buy(P)556K——556K
Dec 23, 2024Buy(P)556K——556K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-132188) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Quoin Pharmaceuticals, Ltd.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp